Daniel K. Crawford

Daniel K. Crawford

Auto-generated profile, based on publicly available information

Daniel K. Crawford

Eloxx Pharmaceuticals, Inc., 950 Winter Street, Waltham, MA 02451 USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2010 in Brain
Verified
Journal Article
Open access
PDF file
DCDaniel K. Crawford
Daniel K. Crawford
MMMario Mangiardi
Mario Mangiardi
BSBingbing Song
Bingbing Song
RPRhusheet Patel
Rhusheet Patel
SDSienmi Du
Sienmi Du
STSeema K. Tiwari-Woodruff
Seema K. Tiwari-Woodruff
Demyelinating diseases, such as multiple sclerosis, are characterized by inflammatory demyelination and neurodegeneration of the central nervous system. Therapeutic strategies that induce effective neuroprotection and enhance intrinsic repair mechanisms are central goals for future therapy of multiple sclerosis. Oestrogens and oestrogen receptor ligands are promising treatments to prevent multiple sclerosis-induced neurodegeneration. In the present study we investigated the capacity of oestrogen receptor β ligand treatment to affect callosal axon demyelination and stimulate endogenous myelination in chronic experimental autoimmune encephalomyelitis using electrophysiology, electron microscopy, immunohistochemistry and tract-tracing methods. Oestrogen receptor β ligand treatment of experimental autoimmune encephalomyelitis mice prevented both histopathological and functional abnormalities of callosal axons despite the presence of inflammation. Specifically, there were fewer demyelinated, damaged axons and more myelinated axons with intact nodes of Ranvier in oestrogen receptor β ligand-treated mice. In addition, oestrogen receptor β ligand treatment caused an increase in mature oligodendrocyte numbers, a significant increase in myelin sheath thickness and axon transport. Functional analysis of callosal axon conduction showed a significant improvement in compound action potential amplitudes, latency and in axon refractoriness. These findings show a direct neuroprotective effect of oestrogen receptor β ligand treatment on oligodendrocyte differentiation, myelination and axon conduction during experimental autoimmune encephalomyelitis.

1 August 2013 in Neurobiology of Disease
Verified
Journal Article
Closed access
SKShalini Kumar
Shalini Kumar
RPRhusheet Patel
Rhusheet Patel
SMSpencer Moore
Spencer Moore
DCDaniel K. Crawford
Daniel K. Crawford
NSNirut Suwanna
Nirut Suwanna
STSeema K. Tiwari-Woodruff
Seema K. Tiwari-Woodruff

1 December 2009 in Neuroscience
Verified
Journal Article
Closed access
DCD.K. Crawford
D.K. Crawford
MMM. Mangiardi
M. Mangiardi
XXX. Xia
X. Xia
HLHéctor E López-Valdés
Héctor E López-Valdés
STS.K. Tiwari-Woodruff
S.K. Tiwari-Woodruff

1 August 2009 in Journal of Neuroscience Methods
Verified
Journal Article
Closed access
DCDaniel K. Crawford
Daniel K. Crawford
MMMario Mangiardi
Mario Mangiardi
STSeema K. Tiwari-Woodruff
Seema K. Tiwari-Woodruff

10 November 2010 in Brain Pathology
Verified
Journal Article
Closed access
MMMario Mangiardi
Mario Mangiardi
DCDaniel K. Crawford
Daniel K. Crawford
XXXiaoyu Xia
Xiaoyu Xia
SDSienmi Du
Sienmi Du
RSRebecca Simon‐Freeman
Rebecca Simon‐Freeman
STSeema K. Tiwari‐Woodruff
Seema K. Tiwari‐Woodruff

11 January 2013 in Brain Pathology
Verified
Journal Article
Closed access
PDF file
RPRhusheet Patel
Rhusheet Patel
SMSpencer Moore
Spencer Moore
DCDaniel K. Crawford
Daniel K. Crawford
GHGemmy Hannsun
Gemmy Hannsun
MSManda V. Sasidhar
Manda V. Sasidhar
STSeema K. Tiwari‐Woodruff
Seema K. Tiwari‐Woodruff